Definitive Contract 75N91021C00024
Award Date
9/16/21
Potential Completion Date
6/15/22
Potential Value
$455K
Federal Agency
National Cancer Institute
Awardee
Omicscraft LLC
Ultimate Awardee
Omicscraft LLC
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Washington, DC 20001, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
11
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The National Cancer Institute (NCI) awarded a $2,000,000 firm fixed price contract to Omicscraft LLC, a minority-owned small disadvantaged business, to develop the ISYSMET: AI-Powered Platform for Integrative Analysis of Multimodal Data. This contract has a total small business set-aside. The platform will support biomedical research initiatives by providing cloud-based capabilities for integrative analysis of multi-omics and imaging data. Omicscraft LLC has previously delivered similar...
This contract was awarded by the National Cancer Institute, part of the Department of Health and Human Services National Institutes of Health, to Omicscraft LLC, a minority-owned, self-certified small disadvantaged business. The contract, valued at $272,135.01, is a Firm Fixed Price Definitive Contract for a Phase I SBIR (Small Business Innovation Research) project under Topic #364 titled "SYSMET: INTEGRATIVE SYSTEMS METABOLOMICS". The contract has a completion date of June 10, 2018...
<p>The U.S. Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a Small Business Innovation Research (SBIR) Phase I firm-fixed-price contract to Mediomics LLC, a woman-owned small business, to develop novel tools for site-specific quantitative analysis of RNA modifications. The contract has a potential value of $248,357.00 and a completion date of June 18, 2018.</p>
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Infotech Soft, Inc., a woman-owned small business. The contract, valued at $223,808.00, is for the development of a "Platform for High-Throughput Analysis of Integrated Cancer Imaging and Multi-Omics Data" under SBIR Topic #364. The contract is a Definitive Contract with a Firm Fixed Price...
The National Cancer Institute (NCI) awarded a Firm Fixed Price Definitive Contract to Navipoint Genomics LLC, a minority-owned small business, under the SBIR Program Phase II. The contract, valued at $1,679,321.00, is for the development of cloud-based software to support the Cancer Research Data Commons project. This project aims to enable precision oncology by facilitating collaboration in the cloud. The contract has a completion date of May 31, 2025 and is set aside for small businesses.
<p>This is a $299,999.00 Firm Fixed Price contract awarded by the National Cancer Institute, a civilian agency, to Innogenomics Technologies, L.L.C., a minority-owned small business, under the Small Business Innovation Research (SBIR) Program Phase I. The contract is for research and development in the area of biomedical (basic research). It was awarded on September 22, 2015 with a final completion date of March 21, 2017. The contract has a total small business set-aside designation.</p>
This SBIR Phase I contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Navipoint Genomics LLC, a minority-owned and Asian-Pacific American-owned limited liability company. The $251,927 firm-fixed-price contract is for the development of cloud-based software in support of the Cancer Research Data Commons. This contract was issued under the total small business set-aside NIH SBIR solicitation PHS-2020-1, which...
This federal contract was awarded by the Department of Health and Human Services' National Institutes of Health National Cancer Institute (NCI) to Inlighta Biosciences L.L.C., a woman-owned small business. The $298,230.00 firm fixed-price contract is for a Phase I Small Business Innovation Research (SBIR) project titled "Non-Invasive Subtyping of Aggressive Tumor and Its Environment" as part of the NCI Cancer Moonshot initiative. The original solicitation was issued under the NIH/CDC...
This Small Business Innovation Research (SBIR) Phase I contract, valued at $399,674, was awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Inso Biosciences Inc., a small biotechnology startup. The contract supports the research and development of advanced sample processing platforms for downstream single-cell multi-omic analysis. This work aligns with the NIH and Centers for Disease Control and Prevention (CDC) mission to develop medical...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute awarded a Small Business Innovation Research (SBIR) contract to Mimetas US, Inc., a small disadvantaged business, in the amount of $297,962.00. The contract is for the development of a 3D perfusable platform for high-throughput screening (HTS) across diverse racial/ethnic cancer specimens to generate racially diverse patient-derived xenograft (PDX)-derived prostate cancer cultures in...